Research
Title : | An event-driven, phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficiency, safety, immunogenicity, & lot-to-lot consistency of Bbv152, a whole-varion inactivated Sars-Cov-2 vaccine in adults more than 18 to years of age |
Area of research : | Medical Sciences |
Focus area : | Task Force (TF) |
Principal Investigator : | Mr. M. Shameem Professor ICMR-National Institute of Research In Tribal Health Madhya Pradesh |
Timeline Start Year : | 2020 |
Timeline End Year : | 2021 |
Details
Total Budget (INR): | 15,56,19,311 |
Organizations involved
Implementing Agency : | ICMR-National Institute of Research In Tribal Health Madhya Pradesh |
Funding Agency : | Indian Council of Medical Research (ICMR) |